HPLC
IndustriesFood & Agriculture
ManufacturerKNAUER
Significance of the Topic
Cannabidiol (CBD) has become a prominent compound in health and wellness products, prompting the need for reliable analytical methods to ensure quality, safety, and regulatory compliance in the rapidly growing CBD market.
Objectives and Study Overview
This study applied a validated HPLC-UV method on a KNAUER AZURA® system to compare cannabinoid profiles in seven commercial CBD aroma oils and verify adherence to German narcotics legislation limiting total THC to below 0.2 %.
Methodology and Instrumentation
Sample preparation involved ultrasonic extraction of 50 mg of oil in 10 mL methanol, vortex mixing, and filtration through a 0.20 µm PTFE filter. Chromatographic separation was performed on a Eurospher II C18 column (150 × 4.6 mm, 3 µm) at 25 °C using a water/acetonitrile gradient. Detection wavelengths were set at 228 nm and 306 nm. The method quantified six cannabinoids (CBD, CBDA, CBN, Δ9-THC, Δ8-THC, Δ9-THCA) and qualified up to sixteen analytes within a 22-minute run, following ICH Q2(R1) guidelines.
Main Results and Discussion
All seven oils exhibited total THC levels below the 0.2 % limit; three samples showed no detectable THC. Total CBD levels ranged from approximately 5.0 % to 7.2 %, with one sample slightly deviating from its declared specification. The method demonstrated excellent linearity (R² > 0.9999), repeatability (RSD < 1 %), and low limits of detection (0.05–0.25 µg/mL) and quantification (0.14–0.76 µg/mL). Chromatographic overlays confirmed clear separation and reliable quantification of target cannabinoids.
Benefits and Practical Applications
- Enables routine quality control of CBD oils and related products.
- Ensures compliance with national THC regulations to avoid legal and safety issues.
- Supports high-throughput laboratories with rapid 22-minute analysis cycles.
- Offers robust performance metrics suitable for industrial and regulatory settings.
Future Trends and Potential Applications
Emerging directions include coupling HPLC with mass spectrometry for enhanced sensitivity, expanding methods to novel and minor cannabinoids, implementing online monitoring in production lines, and adapting workflows to evolving international regulatory frameworks.
Conclusion
The KNAUER AZURA® HPLC-UV method provides a fast, precise, and reliable approach for the qualification and quantification of cannabinoids in CBD aroma oils. It effectively verifies product compliance with German narcotics laws and supports quality assurance across the CBD supply chain.
Reference
- German Narcotics Act (BtMG), Annex I, 2001.
- Regulation (EU) 2015/2283 on Novel Foods.
- German Federal Institute for Risk Assessment THC guidance for hemp foods, 2000.
- Borsch J. THC in hemp products: permissible limits? DAZ, 2021.
- Loxterkamp L., Stephan S., Monks K. Determination of 16 cannabinoids in flowers, oils, and seeds, KNAUER application note VPH0070, 2019.
- Loxterkamp L., Monks K. Analysis of cannabis flowers per German Pharmacopeia 2018, KNAUER application note VPH0072, 2019.
- German Pharmacopeia (DAB) monograph on cannabinoid analysis, 2018.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.